Stroke prophylaxis in patients with atrial fibrillation

What can we do about it? [6]

Research output: Contribution to journalLetter

Abstract

Friberg et al.1 have shown clearly, like others, that many patients with atrial fibrillation (AF) do not receive stroke prophylaxis. In their summary, they note that it is ‘urgent to increase awareness of the need for adequate stroke prophylaxis in AF patients’. I would like to highlight to the readers that there has been research conducted in Tasmania, Australia on an intervention which aimed to increase warfarin use in those at risk of stroke. Jackson et al.2 mailed guidelines, which were developed in consultation with local specialists, to 272 general practitioners and then approximately 60% of these were visited to discuss the guidelines. Jackson et al. showed that this form of ‘academic detailing’ was effective at increasing warfarin use in the intervention area compared with a control region (P < 0.001), which did not receive the guidelines and academic detailing. Furthermore, hospital admission data (in the intervention area) collected before and after the intervention showed a significant increase in the use of warfarin in patients at high risk of stroke (33 vs. 46% of eligible patients; P < 0.05).
Original languageEnglish
Pages (from-to)1172-1173
Number of pages2
JournalEuropean Heart Journal
Volume28
Issue number9
DOIs
Publication statusPublished - 1 May 2007
Externally publishedYes

Fingerprint

Atrial Fibrillation
Warfarin
Stroke
Guidelines
Tasmania
General Practitioners
Referral and Consultation
Research

Cite this

@article{78452d936341413eb59c446b0135792d,
title = "Stroke prophylaxis in patients with atrial fibrillation: What can we do about it? [6]",
abstract = "Friberg et al.1 have shown clearly, like others, that many patients with atrial fibrillation (AF) do not receive stroke prophylaxis. In their summary, they note that it is ‘urgent to increase awareness of the need for adequate stroke prophylaxis in AF patients’. I would like to highlight to the readers that there has been research conducted in Tasmania, Australia on an intervention which aimed to increase warfarin use in those at risk of stroke. Jackson et al.2 mailed guidelines, which were developed in consultation with local specialists, to 272 general practitioners and then approximately 60{\%} of these were visited to discuss the guidelines. Jackson et al. showed that this form of ‘academic detailing’ was effective at increasing warfarin use in the intervention area compared with a control region (P < 0.001), which did not receive the guidelines and academic detailing. Furthermore, hospital admission data (in the intervention area) collected before and after the intervention showed a significant increase in the use of warfarin in patients at high risk of stroke (33 vs. 46{\%} of eligible patients; P < 0.05).",
author = "Mark Naunton",
year = "2007",
month = "5",
day = "1",
doi = "10.1093/eurheartj/ehm057",
language = "English",
volume = "28",
pages = "1172--1173",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "9",

}

Stroke prophylaxis in patients with atrial fibrillation : What can we do about it? [6]. / Naunton, Mark.

In: European Heart Journal, Vol. 28, No. 9, 01.05.2007, p. 1172-1173.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Stroke prophylaxis in patients with atrial fibrillation

T2 - What can we do about it? [6]

AU - Naunton, Mark

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Friberg et al.1 have shown clearly, like others, that many patients with atrial fibrillation (AF) do not receive stroke prophylaxis. In their summary, they note that it is ‘urgent to increase awareness of the need for adequate stroke prophylaxis in AF patients’. I would like to highlight to the readers that there has been research conducted in Tasmania, Australia on an intervention which aimed to increase warfarin use in those at risk of stroke. Jackson et al.2 mailed guidelines, which were developed in consultation with local specialists, to 272 general practitioners and then approximately 60% of these were visited to discuss the guidelines. Jackson et al. showed that this form of ‘academic detailing’ was effective at increasing warfarin use in the intervention area compared with a control region (P < 0.001), which did not receive the guidelines and academic detailing. Furthermore, hospital admission data (in the intervention area) collected before and after the intervention showed a significant increase in the use of warfarin in patients at high risk of stroke (33 vs. 46% of eligible patients; P < 0.05).

AB - Friberg et al.1 have shown clearly, like others, that many patients with atrial fibrillation (AF) do not receive stroke prophylaxis. In their summary, they note that it is ‘urgent to increase awareness of the need for adequate stroke prophylaxis in AF patients’. I would like to highlight to the readers that there has been research conducted in Tasmania, Australia on an intervention which aimed to increase warfarin use in those at risk of stroke. Jackson et al.2 mailed guidelines, which were developed in consultation with local specialists, to 272 general practitioners and then approximately 60% of these were visited to discuss the guidelines. Jackson et al. showed that this form of ‘academic detailing’ was effective at increasing warfarin use in the intervention area compared with a control region (P < 0.001), which did not receive the guidelines and academic detailing. Furthermore, hospital admission data (in the intervention area) collected before and after the intervention showed a significant increase in the use of warfarin in patients at high risk of stroke (33 vs. 46% of eligible patients; P < 0.05).

UR - http://www.scopus.com/inward/record.url?scp=34548295399&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehm057

DO - 10.1093/eurheartj/ehm057

M3 - Letter

VL - 28

SP - 1172

EP - 1173

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 9

ER -